Abiopharma

(80% Positive) Trinseo SA (TSE) Files Form 8-K

(10% Negative) Karyopharm Therapeutics Inc (KPTI) Announces Delay in care Trials for myelofibrosis expected in March Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) BioXcel Therapeutics Inc. (BTAI) Announces Clinical Development Update

Brookdale Senior Living Inc. - Brookdale Reports December 2025 Occupancy

MindMed Rebrands to Definium Therapeutics, Advancing a Leading Late-Stage Psychiatry Pipeline with Three Phase 3 Readouts Expected in 2026

(75% Positive) Moderna Inc (MRNA) Announces Enrollment Update for disease Due to Pandemic-Related Challenges, Patient Enrollment Issues

Precision BioSciences Sets Strategic Priorities for 2026 Focused on Continued Advancement of Clinical-Stage Programs PBGENE-HBV for Chronic Hepatitis B and PBGENE-DMD for Duchenne Muscular Dystrophy

(90% Positive) Neoleukin Therapeutics Inc (was merged wih Neurogene (NASDAQ: NGNE) on 19/12/23) (NLTX) Provides Update on Milestones for our Phase 1/2 trial

(90% Positive) Ionis Pharmaceuticals Inc (IONS) Announces Enrollment Update for bepirovirsen Due to Patient Enrollment Issues, Regulatory Process, Safety Review

(85% Positive) Novocure Ltd (NVCR) Announces Enrollment Update for updates Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review

(90% Positive) Pieris Pharmaceuticals Inc. (PIRS) Announces Enrollment Update for contained Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(99% Neutral) XOMA Corporation (XOMAO) Files Form 8-K

Relmada Therapeutics Provides Regulatory Update Confirming FDA Alignment on Registrational Studies Design for NDV-01 for Two Separate Indications

(85% Positive) Neumora Therapeutics Inc. (NMRA) Announces Enrollment Update for life Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) Henry Schein Inc (HSIC) Files Form 8-K